In addition, potential new target sites based on these pathogen-host interactions could be explored for development of potent antibiotics and new therapeutic methods.
Traditional treatments for allergic diseases have some limitations such as efficacy deficiency or severe side effect, thus new targets are being explored for development of new drugs.
Targeting the sterol biosynthesis pathway has been explored for the development of new bioactive compounds.
For this reason, it has been explored for the development of biologically instructive biomaterials with applications for tissue substitution and regeneration.
The inherent property of PANI to adsorb dyes has been explored for the development of electrochemical detection of dye in solution.
In particular, new avenues have been explored for the development of a fast operational algorithm for the retrieval of ozone profiles, including a new forward model based on perturbation theory that is faster than the current operational algorithm, coupled to a new inversion scheme with no use of a-priori ozone profile information.
Interestingly, only a third of these GPCRs have been explored for drug development portending a future active area of research for the discovery of novel therapeutics [ 26, 27].
To date, a wide range of macromolecules, such as perfluorocarbon emulsions, silica nanoparticles, liposomal vesicles, dendrimers, and polymers, have been explored for the development of gadolinium-based T1 contrast agents.
The intranasal administration of the viral entry inhibitor peptide T has recently been explored for the prevention of neuro-AIDS development such as cognitive impairment associated with HIV.
Development of gene therapy for OA has also been explored for OA prevention and treatment.
